A critical breakthrough in cancer study is arising with the use of VHH fragments to reactivate dysfunctional p53. This essential tumor protector protein is frequently inactivated in several kinds of malignancies, https://bookmark-group.com/story7727013/vhh-fragments-revive-p53-new-new-hope-for-tumor-therapy